Unlabelled: Patau syndrome has an incidence of 1/10.000-20.000, the clinical diagnosis being suggested by the triad cleft lip and palate, microphthalmia/anophthalmia and postaxial polydactyly. Most frequent cytogenetic abnormality is free and homogeneous trisomy 13 (80.0%), rarely being detected trisomy mosaics or Robertsonian translocations. The objective of the study was to identify phenotypic features of trisomy 13.

Material And Methods: The retrospective study was conducted on a trial group of 14 cases diagnosed cytogenetically with trisomy 13 between January 2000 and December 2012 at lasi Medical Genetics Centre.

Results: Of the 14 cases, 3 were evaluated pathologically (two aborted foetuses and one stillborn), 8 cases were detected in the neonatal period, and 3 in infancy. Clinical diagnosis was supported by the identification of a model of abnormal development, mainly characterized by: maxillary cleft (lip and palate--5 cases; lip--1 case), ocular abnormalities (microphthalmia/anophthalmia--7 cases; cyclopia--1 case), postaxial polydactyly (7 cases), scalp defects (6 cases), congenital heart anomalies (10 cases, 6 patients with atrial septal defect), complete holoprosencephaly (4 cases), ear abnormalities (11 cases), broad nasal root (10 cases). An important issue in confirming the phenotypic variability of Patau syndrome is that the classic clinical triad was identified only in one case.

Conclusions: Patau syndrome is a disease with variable expression and is characterized by a pattern of abnormal prenatal development characterized by facial dysmorphia, polydactyly and severe birth defects (heart, brain) that generate an increased in utero and perinatal mortality.

Download full-text PDF

Source

Publication Analysis

Top Keywords

patau syndrome
16
cases
11
phenotypic variability
8
variability patau
8
clinical diagnosis
8
cleft lip
8
postaxial polydactyly
8
development characterized
8
patau
4
syndrome
4

Similar Publications

Objective: To report the diagnostic accuracy of cell-free fetal DNA (cfDNA) in detecting fetal chromosomal anomalies in women experiencing miscarriage.

Methods: PubMed, MEDLINE, EMBASE and Cochrane databases were searched from inception to June 2024. The inclusion criteria were women experiencing miscarriage (defined as pregnancy loss before 20 weeks of gestation) who underwent cfDNA screening for trisomies 21, 18 and 13, other autosomal aneuploidies, sex-chromosome aneuploidies and/or copy-number variants (CNVs).

View Article and Find Full Text PDF

Opioid-Free Anesthesia for a Child With Patau Syndrome With External Oblique Intercostal Fascial Plane Blocks.

Paediatr Anaesth

December 2024

Department of Anaesthesiology and Intensive Care, Children's Health Ireland at Crumlin, Dublin, Ireland.

View Article and Find Full Text PDF

Massive parallel sequencing-based non-invasive prenatal test (NIPT) identifies aberrations on chromosome 13.

Eur J Obstet Gynecol Reprod Biol

November 2024

Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden; Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden. Electronic address:

Article Synopsis
  • * A total of 4,532 NIPT tests were performed, with 125 indicating an increased risk for trisomies 13, 18, 21, and sex chromosome abnormalities; further testing revealed other chromosomal issues not covered by standard NIPT.
  • * The findings showcase the ability of NIPT to detect complex chromosomal abnormalities, such as segmental duplications and mosaicism, underscoring its potential for genome-wide screening of copy number variations. *
View Article and Find Full Text PDF

Trisomy 13, home health-care and multidisciplinary approach: Case report.

Rev Paul Pediatr

October 2024

Faculdade Ciências Médicas de Minas Gerais, Post-Graduate Program in Health Sciences, Belo Horizonte, MG, Brazil.

Article Synopsis
  • The objective of the text is to highlight the importance of recognizing and addressing Patau's syndrome through a case study of a 2-year-old patient receiving extensive Home Care services.
  • The case describes a female patient who underwent a cesarean delivery due to restricted growth and was diagnosed with Patau's syndrome at birth, yet has survived longer than expected with specialized home-based care.
  • The comments emphasize that a multidisciplinary care approach, including medical and psychological support, has led to positive outcomes and stresses the importance of support networks for families dealing with similar illnesses.*
View Article and Find Full Text PDF

Amniotic fluid glucose concentration as a predictor of fetal trisomy.

J Obstet Gynaecol Res

November 2024

Division of Obstetrics and Gynaecology, Department of Reproductive and Developmental Medicine, Akita University Graduate School of Medicine, Akita, Japan.

Aim: We aimed to assess the amniotic fluid glucose concentration cut-off as an indicator of fetal chromosomal abnormalities, such as trisomy 13, 18, and 21.

Methods: This prospective observational study included pregnant females who underwent amniocentesis. Participants were divided into two groups on the border of 22 weeks of gestational age (<22 and ≥22-week groups).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!